Skip to main content

Table 1 Analysis of participant’s characteristics by DTT in children

From: Discontinuation of tuberculosis treatment among children in the Kampala Capital City Authority health facilities: a mixed-methods study

Characteristics

Level

Total

(n = 312)

DTT

p-value

No (n = 277)

Yes (n = 35)

Age categories (years)

0–5

75 (24.0)

63 (22.7)

12 (34.3)

0.221

6–10

125 (40.1)

115 (41.5)

10 (28.6)

11–15

112 (35.9)

99 (35.7)

13 (37.1)

Sex

Female

203 (65.1)

185 (66.8)

18 (51.4)

0.09

Male

109 (34.9)

92 (33.2)

17 (48.6)

Type of person with TB

New

255 (81.7)

232 (83.8)

23 (65.7)

0.018

Retreatment

57 (18.3)

45 (16.2)

12 (34.3)

TB disease classification

BC-PTB

87 (27.9)

77 (27.8)

10 (28.6)

0.054

CD-PTB

178 (57.1)

163 (58.8)

15 (42.9)

EPTB

47 (15.1)

37 (13.4)

10 (28.6)

Type of DOTS

FB-DOTS

16 (5.1)

11 (4.0)

5 (14.3)

0.023

CB-DOTS

296 (94.9)

266 (96.0)

30 (85.7)

Anti-TB regimen

2RHZE/6HE

100 (32.1)

93 (33.6)

7 (20.0)

0.125

2RHZE/4RH

212 (67.9)

184 (66.4)

28 (80.0)

TB/HIV co-infection

No

251 (80.4)

228 (82.3)

23 (65.7)

0.039

Yes

61 (19.6)

49 (17.7)

12 (34.3)

Residence

Rural

112 (35.9)

95 (34.3)

17 (48.6)

0.133

Urban

200 (64.1)

182 (65.7)

18 (51.4)

Origin of referral

Community

16 (5.1)

13 (4.7)

3 (8.6)

0.404

Facility

296 (94.9)

264 (95.3)

32 (91.4)

Phase of treatment

Intensive

256 (82.1)

231 (83.4)

25 (71.4)

0.100

Continuation

56 (17.9)

46 (16.6)

10 (28.6)

Treatment supporter marital status

Married

198 (63.5)

176 (63.5)

22 (62.9)

0.151

Separated

58 (18.6)

48 (17.3)

10 (28.6)

Single

56 (17.9)

53 (19.1)

3 (8.6)

Treatment supporter is employed

No

181 (58.0)

166 (59.9)

15 (42.9)

0.069

Yes

131 (42.0)

111 (40.1)

20 (57.1)

Relationship between the treatment supporter and child with TB

Grand parents

45 (14.4)

41 (14.8)

4 (11.4)

0.937

Biological parents

174 (55.8)

154 (55.6)

20 (57.1)

Other relatives

93 (29.8)

82 (29.6)

11 (31.4)

Treatment supporter received counseling at the time of TB treatment initiation

No

48 (15.4)

38 (13.7)

10 (28.6)

0.042

Yes

264 (84.6)

239 (86.3)

25 (71.4)

  1. Note: 1) BC-PTB: Bacteriologically confirmed pulmonary tuberculosis; 2) CB-DOTS: Community-based Directly Observed Therapy Short Course; 3) CD-PTB: Clinically diagnosed pulmonary tuberculosis; 4) FB-DOTS: Facility-based Directly Observed Therapy Short Course; 5) RHZE: Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol